Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 291
Selected: 0
NCT IDTitle
NCT00005986Chemotherapy, Filgrastim and Peripheral Stem Cell Transplantation in Patients With Chronic Myelogenous Leukemia
NCT04105270RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
NCT03981705Assessment of Complete Pathologic Response After Neoadjuvant Chemotherapy for Breast Cancer
NCT00748163Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer
NCT01343368Preservation of Ovarian Function After Hematopoietic Cell Transplant
NCT00638820Reduced Intensity AlloTransplant For Osteopetrosis
NCT03850704Single Patient Use of Selinexor and Dexamethasone for a Patient With Multiple Myeloma
NCT02845414Study of CD133KDEL Toxin in the Treatment for Solid Tumors
NCT07008638Phase I/II Clinical Trial of Proteasome Inhibitor in Combination With CPX-351 for the Treatment of Newly-Diagnosed TP53-mutated Acute Myeloid Leukemia (AML)
NCT03557749Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
NCT00871689Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML
NCT04629209A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma
NCT00818649Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
NCT02227797MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients
NCT03934840CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
NCT00176865Stem Cell Transplant for Immunologic or Histiocytic Disorders
NCT04555811FT596 With Rituximab as Relapse Prevention After Autologous HSCT for NHL
NCT06772090Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies
NCT06594445HM2023-05: GTB-3650 Trike for High Risk MDS and R/R AML
NCT06544811American Indian Smokefree Native RCT
NCT01099631IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread
NCT07070726UNTOLD Ovarian Cancer Unmet Needs Survey
NCT06792825HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL
NCT00276159Study of Immune Response Modifier in the Treatment of Hematologic Malignancies
NCT00003926Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
NCT06322992App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3
NCT04714372FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
NCT04466098Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
NCT02162420Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
NCT00000105Vaccination With Tetanus and KLH to Assess Immune Responses.
NCT00869323Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders
NCT05123040Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
NCT02156674Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome
NCT06377540MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma
NCT02042924Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies
NCT00005985Filgrastim and Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Patients With Hodgkin's Lymphoma or Non-Hodgkin's Lymphoma
NCT03678493A Study of FMT in Patients With AML Allo HSCT in Recipients
NCT03050216QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML
NCT00623077MT2004-30: Tomotherapy for Solid Tumors
NCT03383055CMV-MVA Triplex Vac.Enhance Adap. NK Cell Recon. After Auto HSCT in pt Lymphoid Malig
NCT06692426Trial of Cell Based Therapy for DMD
NCT05665543Increasing HPV Vaccination in Pediatric, Adolescent, and Young Adult (PAYA) Cancer Survivors
NCT02171104MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
NCT06295757Effects of Relighting on Smoke Toxicant Deliveries and Subjective Smoking Measures
NCT01593670Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes
NCT00622674Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
NCT02991898Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
NCT00365547Topotecan and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Did Not Respond to Previous Systemic Chemotherapy
NCT00293293Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
NCT02666105Exemestane in Post-Menopausal Women With NSCLC